I work with a highly collaborative team in the Institute for Vision Research whose mission is to cure blindness by elucidating key pathways of retinal disease and developing breakthrough treatments. My research involves a multidisciplinary approach that synthesizes insights from advanced retinal imaging and translational models. Current treatments in development use cutting-edge technologies such as viral vector-mediated gene therapy, sustained drug delivery with nanoparticles and 3D-printed biomaterials, and retinal cell replacement with patient-derived autologous induced pluripotent stem cell grafts. I also lead a Retinal Imaging and Modeling (RIM) Lab that uses computational methods for analyzing multimodal imaging data toward improved understanding of pathophysiologic mechanisms and guiding clinical trial design. Synergistic to these efforts is my practice as a vitreoretinal surgeon which informs and motivates scientific pursuits from the clinic to the lab and back.